{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:50:02Z","timestamp":1761706202049},"publisher-location":"Chichester, UK","reference-count":67,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005451","type":"reference-entry","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T17:18:45Z","timestamp":1120497525000},"source":"Crossref","is-referenced-by-count":18,"title":["Carbamazepine for acute and chronic pain in adults"],"prefix":"10.1002","author":[{"given":"Philip J","family":"Wiffen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry J","family":"McQuay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,7,20]]},"reference":[{"key":"10.1002\/14651858.CD005451-BIB1|cit1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp.29.3.265","article-title":"Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia","volume":"29","author":"Campbell","year":"1966","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD005451-BIB2|cit2","first-page":"104","article-title":"Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia","volume":"53","author":"Gerson","year":"1977","journal-title":"Postgraduate Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD005451-BIB3|cit3","first-page":"525","article-title":"Nortriptyline-Fluphenazine vs Carbamazepine in the symptomatic treatment of diabetic neuropathy","volume":"27","author":"Gomez-Perez","year":"1996","journal-title":"Archives of Medical Research"},{"key":"10.1002\/14651858.CD005451-BIB4|cit4","first-page":"321","article-title":"Effects of Venlafaxine and Carbamazepine for painful peripheral diabetic neuropathy: A randomized double blind and double dummy controlled multicenter trial","volume":"6","author":"Jia","year":"2006","journal-title":"Chinese Journal of Evidence Based Medicine"},{"key":"10.1002\/14651858.CD005451-BIB5|cit5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2133.1980.tb07654.x","article-title":"Do corticosteroids prevent post-herpetic neuralgia?","volume":"102","author":"Keczkes","year":"1980","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005451-BIB6|cit6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1968.00480020015001","article-title":"Carbamazepine in the treatment of neuralgia. Use and side effects","volume":"19","author":"Killian","year":"1968","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD005451-BIB7|cit7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/archneur.1989.00520450030015","article-title":"Pimozide therapy for trigeminal neuralgia","volume":"46","author":"Lechin","year":"1989","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD005451-BIB8|cit8","first-page":"102","article-title":"A controlled trial of amitriptyline and carbamazepine in central post stroke pain","volume":"77(Suppl 116)","author":"Leijon","year":"1988","journal-title":"Acta Nuerologica Scandanavica"},{"key":"10.1002\/14651858.CD005451-BIB9|cit9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0304-3959(89)90108-5","article-title":"Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine","volume":"36","author":"Leijon","year":"1989","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451-BIB10|cit10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(87)91058-X","article-title":"The analgesic effect of tocainide in trigeminal neuralgia","volume":"28","author":"Lindstrom","year":"1987","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451-BIB11|cit11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1526-4610.1969.hed0901054.x","article-title":"A four year double blind study of tegretol in facial pain","volume":"9","author":"Nicol","year":"1969","journal-title":"Headache"},{"key":"10.1002\/14651858.CD005451-BIB12|cit12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0404.1970.tb05803.x","article-title":"Facial pain treated with carbamazepin (Tegretol)","volume":"46","author":"Rasmussen","year":"1970","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD005451-BIB13|cit13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1966.00470140019003","article-title":"Controlled sequential trials of Carbamazepine in trigeminal neuralgia","volume":"15","author":"Rockliff","year":"1966","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD005451-BIB14|cit14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01212087","article-title":"Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: double-blind crossover study","volume":"5","author":"Rull","year":"1969","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD005451-BIB15|cit15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1468-2982.1986.0603181.x","article-title":"Tizanidine in the management of trigeminal neuralgia","volume":"6","author":"Vilming","year":"1986","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD005451-BIB16|cit16","first-page":"869","article-title":"Tegretol in the Treatment of Diabetic Neuropathy","volume":"48","author":"Wilton","year":"1974","journal-title":"S-A Mediese Tydskrif"},{"key":"10.1002\/14651858.CD005451-BIB17|cit17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.7326\/0003-4819-79-6-844","article-title":"Carbamazepine","volume":"79","author":"Crill","year":"1973","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005451-BIB18|cit18","first-page":"176","article-title":"The management of chronic pain at spinal cord injured patients","volume":"9","author":"Erzurumlu","year":"1996","journal-title":"Romatoloji ve Tibbi Rehabilitasyon Derg"},{"key":"10.1002\/14651858.CD005451-BIB19|cit19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1213\/00000539-200102000-00039","article-title":"The Response of Neuropathic Pain and Pain in ComplexRegional Pain Syndrome I to Carbamazepine andSustained-Release Morphine in Patients Pretreated withSpinal Cord Stimulation: A Double-BlindedRandomized Study","volume":"92","author":"Harke","year":"2001","journal-title":"Anesthesia and Analgesia"},{"issue":"1","key":"10.1002\/14651858.CD005451-BIB20|cit20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002508-199803000-00009","article-title":"Effect of carbamazepine on pain scores of unipolar depressed patients with chronic pain. A trial of Off-On-Off-On design","volume":"14","author":"Kudoh","year":"1998","journal-title":"The Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD005451-BIB21|cit21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1526-4610.1969.hed0901064.x","article-title":"A long term low doage study of carbamazepine in trigeminal neuralgia","volume":"9","author":"Lloyd-Sith","year":"1969","journal-title":"Headache"},{"issue":"12","key":"10.1002\/14651858.CD005451-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1365-2044.1981.tb08701.x","article-title":"Anticonvulsant drugs used in the treatment of lancinating pain","volume":"36","author":"Swerdlow","year":"1981","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD005451-BIB23|cit23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002826-198403000-00003","article-title":"Anticonvulsant drugs and chronic pain","volume":"7","author":"Swerdlow","year":"1984","journal-title":"Clinical Neuropharmacology"},{"issue":"11-12","key":"10.1002\/14651858.CD005451-BIB24|cit24","first-page":"627","article-title":"A clinical trial of carbamazepine in the symptomatic treatment of diabetic peripheral neuropathy","volume":"58","author":"Badran","year":"1975","journal-title":"The Journal of the Egyptian Medical Association"},{"key":"10.1002\/14651858.CD005451-BIB25|cit25","first-page":"S5","article-title":"Results of a double blind trial comparing oxcarbazepine vs carbamazepine in newly diagnosed, untreated patients with trigeminal neuralgia","volume":"187","author":"Liebel","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD005451-BIB26|cit26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(62)91847-0","article-title":"Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G.32883)","volume":"1","author":"Blom","year":"1962","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005451-BIB27|cit27","first-page":"129","article-title":"Anticonvulsants for the management of pain","volume":"7","author":"Chong","year":"2000","journal-title":"Pain Reviews"},{"key":"10.1002\/14651858.CD005451-BIB28|cit28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14740330903427969","article-title":"Genetic predisposition of life-threatening antiepileptic-induced skin reactions","volume":"9","author":"Chung","year":"2010","journal-title":"Expert Opinion on Drug Safety"},{"key":"10.1002\/14651858.CD005451-BIB29|cit29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/sim.4780080408","article-title":"How study design affects outcomes in comparisons of therapy","volume":"8","author":"Colditz","year":"1989","journal-title":"Statistical Methods in Medical Research"},{"key":"10.1002\/14651858.CD005451-BIB30|cit30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"issue":"6970","key":"10.1002\/14651858.CD005451-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/bmj.309.6970.1677","article-title":"The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?","volume":"309","author":"Counsell","year":"1994","journal-title":"BMJ"},{"volume-title":"Assessing the Effects of Health Technologies","year":"1992","key":"10.1002\/14651858.CD005451-BIB32|cit32"},{"issue":"2","key":"10.1002\/14651858.CD005451-BIB33|cit33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"The Journal of Pain"},{"key":"10.1002\/14651858.CD005451-BIB34|cit34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jama.1993.03510040124050","article-title":"Three battles to watch in the 1990s","volume":"270","author":"Eddy","year":"1993","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD005451-BIB35|cit35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD005451-BIB36|cit36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451-BIB37|cit37","article-title":"Oxford Textbook of Clinical Pharmacology and Drug Therapy","volume-title":"Oxford Textbook of Clinical Pharmacology and Drug Therapy","author":"Grahame-Smith","year":"1992"},{"key":"10.1002\/14651858.CD005451-BIB38|cit38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Practice"},{"issue":"4","key":"10.1002\/14651858.CD005451-BIB39|cit39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00228-006-0104-4","article-title":"The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose","volume":"62","author":"Herman","year":"2006","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD005451-BIB40|cit40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451-BIB41|cit41","unstructured":"Jacox A Carr DB Payne R Management of cancer pain. Clinical Practice Guideline No. 9. Agency for Health Care Policy and Research Rockville, Maryland US Department of Health and Human Services, Public Health Service"},{"volume-title":"Meta-analysis of randomised clinical trials in pain relief [DPhil thesis]","year":"1994","author":"Jadad-Bechara","key":"10.1002\/14651858.CD005451-BIB42|cit42"},{"issue":"1","key":"10.1002\/14651858.CD005451-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"6","key":"10.1002\/14651858.CD005451-BIB44|cit44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archinte.1996.00440060089011","article-title":"The importance of quality of primary studies in producing unbiased systematic reviews","volume":"156","author":"Khan","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"1-3","key":"10.1002\/14651858.CD005451-BIB45|cit45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"volume-title":"An evidence-based resource for pain relief","year":"1998","author":"McQuay","key":"10.1002\/14651858.CD005451-BIB46|cit46"},{"key":"10.1002\/14651858.CD005451-BIB47|cit47","article-title":"Chronic Pain","volume-title":"Health Care Needs Assessment","author":"McQuay","year":"2007"},{"issue":"3","key":"10.1002\/14651858.CD005451-BIB48|cit48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pain.2008.01.014","article-title":"Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain","volume":"135","author":"McQuay","year":"2008","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451-BIB49|cit49","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","article-title":"Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian journal of dermatology, venereology and leprology"},{"issue":"3","key":"10.1002\/14651858.CD005451-BIB50|cit50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"issue":"7128","key":"10.1002\/14651858.CD005451-BIB51|cit51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/bmj.316.7128.333","article-title":"Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs","volume":"316","author":"Moore","year":"1998","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005451-BIB52|cit52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005451-BIB53|cit53","first-page":"April 12","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"Online","author":"Moore","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD005451-BIB54|cit54","first-page":"Epub ahead of p","article-title":"Clinical effectiveness: An approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"Sept 10","author":"Moore","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD005451-BIB55|cit55","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451-BIB56|cit56","article-title":"\u2018\u2018Evidence\u201d in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"epub ahead of p","author":"Moore","year":"2010","journal-title":"Pain"},{"key":"10.1002\/14651858.CD005451-BIB57|cit57","first-page":"436","article-title":"Drugs effective in the therapy of the epilepsies","volume-title":"The pharmacological basis of therapeutics","author":"Rall","year":"1992"},{"key":"10.1002\/14651858.CD005451-BIB58|cit58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0197-2456(94)90106-6","article-title":"Failure to conceal treatment allocation schedules in trials influences estimates of treatment effects","volume":"15","author":"Schulz","year":"1994","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005451-BIB59|cit59","first-page":"353","volume-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2005"},{"issue":"5","key":"10.1002\/14651858.CD005451-BIB60|cit60","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","article-title":"Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"issue":"663","key":"10.1002\/14651858.CD005451-BIB61|cit61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/pgmj.57.663.16","article-title":"Long-term treatment of trigeminal neuralgia with carbamazepine","volume":"57","author":"Taylor","year":"1981","journal-title":"Postgraduate Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD005451-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jpain.2009.09.001","article-title":"How neuroimaging studies have challenged us to rethink: is chronic pain a disease?","volume":"10","author":"Tracey","year":"2009","journal-title":"The Journal of Pain"},{"issue":"20","key":"10.1002\/14651858.CD005451-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.1994.03510440069036","article-title":"The importance of placebo effects in pain treatment and research","volume":"271","author":"Turner","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD005451-BIB64|cit64","article-title":"Gabapentin for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005451-BIB65|cit65","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006044.pub2","article-title":"Lamotrigine for acute and chronic pain","author":"Wiffen","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005451-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain, aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005451-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review","volume":"311","author":"McQuay","year":"1995","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005451\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:49:30Z","timestamp":1628545770000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005451"}},"subtitle":[],"editor":[{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,7,20]]},"references-count":67,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005451","relation":{},"subject":[],"published":{"date-parts":[[2005,7,20]]}}}